BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29784241)

  • 21. Identification of patients with high osteoporosis risk: analysis of FRAX and phalangeal ultrasonography in a female population in North-East Italy.
    Vogrig E; Della Martina M; Xodo S; Ganzitti LP; P Londero A; Fabiani G; Marchesoni D
    Minerva Ginecol; 2014 Oct; 66(5):447-53. PubMed ID: 25245994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density.
    Klop C; de Vries F; Bijlsma JW; Leufkens HG; Welsing PM
    Ann Rheum Dis; 2016 Dec; 75(12):2095-2100. PubMed ID: 26984006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fracture risk among treatment-naïve postmenopausal women with osteopenia in Greece: results from the "ACROSS" study.
    Anastasilakis AD; Makras P
    Arch Osteoporos; 2020 Oct; 15(1):163. PubMed ID: 33067646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between 10-year fracture risk by FRAX and osteoporotic fractures with disease activity in patients with rheumatoid arthritis.
    Phuan-Udom R; Lektrakul N; Katchamart W
    Clin Rheumatol; 2018 Oct; 37(10):2603-2610. PubMed ID: 30039267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the risk of osteoporotic fractures: the Ecuadorian FRAX model.
    Lopez Gavilanez E; Johansson H; McCloskey E; Harvey NC; Segale Bajana A; Marriott Blum D; Navarro Grijalva M; Diaz Curiel M; Kanis JA
    Arch Osteoporos; 2019 Aug; 14(1):93. PubMed ID: 31440846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DUAL-ENERGY X-RAY ABSORPTIOMETRY AND CALCULATED FRAX RISK SCORES MAY UNDERESTIMATE OSTEOPOROTIC FRACTURE RISK IN VITAMIN D-DEFICIENT VETERANS WITH HIV INFECTION.
    Stephens KI; Rubinsztain L; Payan J; Rentsch C; Rimland D; Tangpricha V
    Endocr Pract; 2016 Apr; 22(4):440-6. PubMed ID: 26684149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probability of fractures predicted by FRAX® and observed incidence in the Spanish ECOSAP Study cohort.
    González-Macías J; Marin F; Vila J; Díez-Pérez A
    Bone; 2012 Jan; 50(1):373-7. PubMed ID: 22129640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FRAX-based Estimates of 10-year Probability of Hip and Major Osteoporotic Fracture Among Adults Aged 40 and Over: United States, 2013 and 2014.
    Looker AC; Sarafrazi Isfahani N; Fan B; Shepherd JA
    Natl Health Stat Report; 2017 Mar; (103):1-16. PubMed ID: 28459415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Benign Paroxysmal Positional Vertigo with Osteoporosis and Vitamin D Deficiency: A Case Controlled Study.
    Karataş A; Acar Yüceant G; Yüce T; Hacı C; Cebi IT; Salviz M
    J Int Adv Otol; 2017 Aug; 13(2):259-265. PubMed ID: 28274898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fracture risk assessment tool (FRAX) and for the diagnosis of osteoporosis in Japanese middle-aged and elderly women: Chiba bone survey.
    Oka R; Ohira M; Suzuki S; Yoshida T; Koide H; Tanaka T; Tatsuno I
    Endocr J; 2018 Feb; 65(2):193-202. PubMed ID: 29151451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men.
    Yu R; Leung J; Woo J
    J Am Med Dir Assoc; 2014 Dec; 15(12):918-23. PubMed ID: 25262197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fracture Rates and Bone Density Among Postmenopausal Veteran and Non-Veteran Women From the Women's Health Initiative.
    LaFleur J; Rillamas-Sun E; Colón-Emeric CS; Knippenberg KA; Ensrud KE; Gray SL; Cauley JA; LaCroix AZ
    Gerontologist; 2016 Feb; 56 Suppl 1(Suppl 1):S78-90. PubMed ID: 26768394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A FRAX model for the estimation of osteoporotic fracture probability in Portugal.
    Marques A; Mota A; Canhão H; Romeu JC; Machado P; Ruano A; Barbosa AP; Dias AA; Silva D; Araújo D; Simões E; Aguas F; Rosendo I; Silva I; Crespo J; Alves JD; Costa L; Mascarenhas M; Lourenço Ó; Ferreira PL; Lucas R; Roque R; Branco JC; Tavares V; Johansson H; Kanis J; Pereira da Silva JA
    Acta Reumatol Port; 2013; 38(2):104-12. PubMed ID: 24141347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is It Possible to Increase the Clinical Effectiveness of the Fracture Risk Assessment Tool in Osteopenia Patients by Taking Into Account Bone Mineral Density Values?
    Park JS; Lee J; Park YS
    J Clin Densitom; 2016; 19(3):340-5. PubMed ID: 26822485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX.
    McCloskey EV; Johansson H; Oden A; Austin M; Siris E; Wang A; Lewiecki EM; Lorenc R; Libanati C; Kanis JA
    J Bone Miner Res; 2012 Jul; 27(7):1480-6. PubMed ID: 22431426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Seasonal Variation of Benign Paroxysmal Positional Vertigo.
    Meghji S; Murphy D; Nunney I; Phillips JS
    Otol Neurotol; 2017 Oct; 38(9):1315-1318. PubMed ID: 28796081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of Patients With High Baseline Hip Fracture Risk by FRAX Reduces Hip Fractures-A Post Hoc Analysis of the SCOOP Study.
    McCloskey E; Johansson H; Harvey NC; Shepstone L; Lenaghan E; Fordham R; Harvey I; Howe A; Cooper C; Clarke S; Gittoes N; Heawood A; Holland R; Marshall T; O'Neill TW; Peters TJ; Redmond N; Torgerson D; Kanis JA;
    J Bone Miner Res; 2018 Jun; 33(6):1020-1026. PubMed ID: 29480960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revised FRAX®-based intervention thresholds for the management of osteoporosis among postmenopausal women in Sri Lanka.
    Lekamwasam S; Chandran M; Subasinghe S
    Arch Osteoporos; 2019 Mar; 14(1):33. PubMed ID: 30850909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry.
    Leslie WD; Majumdar SR; Morin SN; Lix LM; Johansson H; Oden A; McCloskey EV; Kanis JA
    Osteoporos Int; 2017 Sep; 28(9):2557-2564. PubMed ID: 28593449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of pharmacotherapy in postmenopausal osteoporosis: a longitudinal observational study.
    Pluskiewicz W; Adamczyk P; Franek E; Sewerynek E; Wichrowska H; Napiórkowska L; Stuss M; Rozwandowicz A; Drozdzowska B
    Endokrynol Pol; 2019; 70(6):473-477. PubMed ID: 31909456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.